Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Negar, Pedram"'
Autor:
Farzad Kakaei, Touraj Asvadi Kermani, Negar Pedram, Milad Asadi, Elham Poursaei, Dariush Karimi
Background Due to poor prognosis and treatment failure, gastric cancer (GC) is still regarded as one of the deadliest malignancies worldwide, demanding new molecular targets for therapeutic and diagnostic approaches. Therefore, the current study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70131c1fc9de2fc8e44394427105f975
https://hdl.handle.net/11454/76254
https://hdl.handle.net/11454/76254
Autor:
Dariush, Karimi, Negar, Pedram, Farzad, Kakaei, Milad, Asadi, Elham, Poursaei, Touraj Asvadi, Kermani
Publikováno v:
Journal of gastrointestinal cancer. 53(2)
Due to poor prognosis and treatment failure, gastric cancer (GC) is still regarded as one of the deadliest malignancies worldwide, demanding new molecular targets for therapeutic and diagnostic approaches. Therefore, the current study was aimed to in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a0c983aa99e3182ba90ed0648cdb0e9e
https://pubmed.ncbi.nlm.nih.gov/33890233
https://pubmed.ncbi.nlm.nih.gov/33890233
Autor:
Mohammad Ali Hosseinpour Feizi, Negar Pedram, Reyhaneh Ravanbakhsh Gavgani, Milad Asadi, Soghra Bornehdeli, Nasser Pouladi, Ebrahim Sakhinia
Publikováno v:
Gene Reports. 20:100785
Background MDM4 is a negative regulator of p53 tumor suppression pathway. Various studies reveal the fact that the rs4245739A>C polymorphism of MDM4 in 3′-untranslated region is targeted by miR-191 which leads to lower MDM4 expression. On the other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cc9e9270dc98d3217ac84a40ff5bd17
https://doi.org/10.1016/j.genrep.2020.100785
https://doi.org/10.1016/j.genrep.2020.100785
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background and Aim: MDM4, a negative regulator of the p53 tumor suppression pathway, has been demonstrated to be overexpressed in a variety of human cancers. Research has revealed that the rs4245739 A>C polymorphism of MDM4 in the 3’-untranslated r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::05db7d46272101002b7710839dfc2f1e
https://pubmed.ncbi.nlm.nih.gov/28547953
https://pubmed.ncbi.nlm.nih.gov/28547953
Autor:
Ebrahim Sakhinia, Mohammad A. Hosseinpour Feizi, Negar Pedram, Nasser Pouladi, Vahid Montazeri, Mehrdad Asghari Estiar
Publikováno v:
Clinical laboratory. 62(7)
Background MDM4 is a negative regulator of the p53 tumor suppression pathway. Recent studies have revealed that the rs4245739 A>C polymorphism of MDM4 in the 3-untranslated region makes it a miR-191 target site which leads to lower MDM4 expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c2fccfefec7e25da56076bd8ee0c02
https://pubmed.ncbi.nlm.nih.gov/28164646
https://pubmed.ncbi.nlm.nih.gov/28164646
Autor:
Shahram Torkamandi, Shaghayegh Taghavi, Saeed Mohammadihosseinabad, Mohammad Reza Abbaszadegan, Neda Shahmohammadibeni, Shokoufeh Abdollahi, Marzieh Motallebi, Negar Pedram, Leyla HaghNejad, Masoumeh Amini Gavenaroudi, Ehsan Ahmadi, Abolfazl Movafagh, Hamid Ghaedi, Babak Emamalizadeh, Amir Ehtesham Shafiei Zarneh, Atena Fazeli, Gholam Ali Shahidi, Hossein Darvish, Javad Jamshidi, Alireza Zare Bidoki, Abbas Tafakhori
Publikováno v:
Journal of the Neurological Sciences. 355:72-74
DNA variations in the fibroblast growth factor 20 gene have been reported to be associated with Parkinson's disease (PD). The rs12720208, a functional SNP located in the 3'UTR region of the gene, was reported as a risk factor for PD. A number of stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60763c4a51a0fb9278bccfe9e686f52f
https://doi.org/10.1016/j.jns.2015.05.020
https://doi.org/10.1016/j.jns.2015.05.020
Autor:
Babak Emamalizadeh, Atefeh Talebi, Abolfazl Movafagh, Seyed Mohammad Hassan Paknejad, Negar Pedram, Leyla HaghNejad, Nilofar Safavi Naeini, Saghar Ghasemi Firouzabadi, Mir Davood Omrani, Eznollah Azargashb, Matin Kayyal, Gholam Ali Shahidi, Ali Khaligh, Javad Jamshidi, Hossein Ashrafian, Hamid Reza Heidari-Rostami, Hossein Darvish, Hamid Noorollahi-Moghaddam, Siamak Karkheiran, Mojdeh Akbari, Siamak Abdi
Publikováno v:
Neuroscience Letters. 551:75-78
Parkinson's disease (PD) is the second most common neurodegenerative disorder, after Alzheimer's disease. Genomic rearrangements are common mutations reported in PD patients. In this study, we investigated the prevalence of genomic rearrangements in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4e99002ccf80ceed1c9f73a24ddc6cf
https://doi.org/10.1016/j.neulet.2013.07.013
https://doi.org/10.1016/j.neulet.2013.07.013